Strong Support

For people with heart disease who are already taking cholesterol-lowering drugs, adding a medicine called evolocumab can cut their risk of heart attack, stroke, or dying from heart problems by 20% over about two years.

74
Pro
0
Against

Evidence from Studies

Supporting (1)

74

Community contributions welcome

The study gave evolocumab to heart disease patients already on statins and found it lowered their risk of heart attack, stroke, or dying from heart problems by 20%, just like the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.